{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T10:48:50Z","timestamp":1772880530680,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82,171,320"],"award-info":[{"award-number":["82,171,320"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015285","name":"Hebei Province Medical Science Research Key Project","doi-asserted-by":"publisher","award":["20231793"],"award-info":[{"award-number":["20231793"]}],"id":[{"id":"10.13039\/501100015285","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.clinthera.2025.07.022","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T20:15:42Z","timestamp":1755893742000},"page":"859-866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety Profiles of Trofinetide in Pediatric Rett Syndrome Population: A Real-World Postmarketing Pharmacovigilance Analysis"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6316-935X","authenticated-orcid":false,"given":"Jingjing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.clinthera.2025.07.022_bib0001","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s40265-023-01883-8","article-title":"Trofinetide: first approval","volume":"83","author":"Keam","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2025.07.022_bib0002","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13023-024-03046-8","article-title":"Rett syndrome in Ireland: a demographic study","volume":"19","author":"Zade","year":"2024","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.clinthera.2025.07.022_bib0003","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/biom11010075","article-title":"Role of DNA methyl-CpG-binding protein MeCP2 in rett syndrome pathobiology and mechanism of disease","volume":"11","author":"Pejhan","year":"2021","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.clinthera.2025.07.022_bib0004","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41583-018-0006-3","article-title":"Rett syndrome: insights into genetic, molecular and circuit mechanisms","volume":"19","author":"Ip","year":"2018","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.clinthera.2025.07.022_bib0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12881-020-0960-2","article-title":"Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with bone disease severity in rett syndrome","volume":"21","author":"Caffarelli","year":"2020","journal-title":"BMC Med Genet"},{"issue":"15","key":"10.1016\/j.clinthera.2025.07.022_bib0006","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.3390\/jcm12155114","article-title":"Trofinetide for rett syndrome: highlights on the development and related inventions of the first USFDA-approved treatment for rare pediatric unmet medical need","volume":"12","author":"Hudu","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.clinthera.2025.07.022_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1284035","article-title":"Trofinetide-a new chapter in rett syndrome\u2019s treatment","volume":"14","author":"Furqan","year":"2023","journal-title":"Front Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.clinthera.2025.07.022_bib0008","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jns.2008.12.003","article-title":"NNZ-2566: a gly-pro-glu analogue with neuroprotective efficacy in a rat model of acute focal stroke","volume":"278","author":"Bickerdike","year":"2009","journal-title":"J Neurol Sci"},{"issue":"16","key":"10.1016\/j.clinthera.2025.07.022_bib0009","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007316","article-title":"Double-blind, randomized, placebo-controlled study of trofinetide in pediatric rett syndrome","volume":"92","author":"Glaze","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2025.07.022_bib0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pediatrneurol.2017.07.002","article-title":"A double-blind, randomized, placebo-controlled clinical study of trofinetide in the treatment of rett syndrome","volume":"76","author":"Glaze","year":"2017","journal-title":"Pediatr Neurol"},{"issue":"6","key":"10.1016\/j.clinthera.2025.07.022_bib0011","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/s41591-023-02398-1","article-title":"Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study","volume":"29","author":"Neul","year":"2023","journal-title":"Nat Med"},{"issue":"13","key":"10.1016\/j.clinthera.2025.07.022_bib0012","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1177\/0883073815579707","article-title":"Improving treatment trial outcomes for rett syndrome: the development of rett-specific anchors for the clinical global impression scale","volume":"30","author":"Neul","year":"2015","journal-title":"J Child Neurol"},{"issue":"2","key":"10.1016\/j.clinthera.2025.07.022_bib0013","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00228-023-03598-x","article-title":"Challenges of pediatric pharmacotherapy: a narrative review of pharmacokinetics, pharmacodynamics, and pharmacogenetics","volume":"80","author":"Watanabe","year":"2024","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2025.07.022_bib0014","series-title":"Signal Analysis in Pharmacovigilance: Principles and Processes","author":"Kumar","year":"2024"},{"issue":"8","key":"10.1016\/j.clinthera.2025.07.022_bib0015","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2165\/00002018-200427080-00010","article-title":"Using MedDRA: implications for risk management","volume":"27","author":"Brown","year":"2004","journal-title":"Drug Saf"},{"key":"10.1016\/j.clinthera.2025.07.022_bib0016","article-title":"The real-world safety of ofatumumab: a pharmacovigilance analysis based on the FDA adverse event reporting system","volume":"16","author":"Zhou","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.clinthera.2025.07.022_bib0017","article-title":"Data mining and safety analysis of voriconazole in patients with a hematological malignant tumor based on the FAERS database: differences between children and adults","volume":"16","author":"Li","year":"2025","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.clinthera.2025.07.022_bib0018","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1097\/MS9.0000000000001896","article-title":"Trofinetide receives FDA approval as first drug for rett syndrome","volume":"86","author":"Mughal","year":"2024","journal-title":"Ann Med Surg (2012)"},{"key":"10.1016\/j.clinthera.2025.07.022_bib0019","doi-asserted-by":"crossref","first-page":"59","DOI":"10.12703\/r\/10-59","article-title":"Rett syndrome: think outside the (skull) box","volume":"10","author":"Borloz","year":"2021","journal-title":"Fac Rev"},{"issue":"9","key":"10.1016\/j.clinthera.2025.07.022_bib0020","first-page":"1178","article-title":"Trofinetide for the treatment of rett syndrome: results from the open-label extension LILAC study","volume":"5","author":"Percy","year":"2024","journal-title":"Med (n Y NY)"},{"issue":"6","key":"10.1016\/j.clinthera.2025.07.022_bib0021","article-title":"Results from the phase 2\/3 DAFFODIL study of trofinetide in girls aged 2-4 years with rett syndrome","volume":"6","author":"Percy","year":"2025","journal-title":"Med (n Y NY)"},{"issue":"1","key":"10.1016\/j.clinthera.2025.07.022_bib0022","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/JOE-13-0414","article-title":"Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS","volume":"221","author":"van Bloemendaal","year":"2014","journal-title":"J Endocrinol"},{"issue":"6","key":"10.1016\/j.clinthera.2025.07.022_bib0023","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/17474124.2024.2368014","article-title":"Recommendations for the management of gastrointestinal comorbidities with or without trofinetide use in rett syndrome","volume":"18","author":"Motil","year":"2024","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clinthera.2025.07.022_bib0024","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/0115426507022002240","article-title":"Ideal body weight in children","volume":"22","author":"Phillips","year":"2007","journal-title":"Nutr Clin Pract: Off Publ Am Soc Parenter Enter Nutr"},{"key":"10.1016\/j.clinthera.2025.07.022_bib0025","article-title":"Nutritional status, food consumption, lifestyle, and physical fitness in rural and urban elementary school children in northeast China","volume":"9","author":"Liu","year":"2022","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.clinthera.2025.07.022_bib0026","first-page":"170","article-title":"The preventable effect of taekwondo sport among cadets and junior\u2019 bone mineral density: DEXA assessment","volume":"10","author":"Ghazzawi","year":"2023","journal-title":"Child (basel Switz)"},{"key":"10.1016\/j.clinthera.2025.07.022_bib0027","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.2147\/DDDT.S383133","article-title":"Profile of trofinetide in the treatment of rett syndrome: design, development and potential place in therapy","volume":"18","author":"Camillo","year":"2024","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.clinthera.2025.07.022_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2023.102815","article-title":"Mechanisms of NMDA receptor regulation","volume":"83","author":"Mony","year":"2023","journal-title":"Curr Opin Neurobiol"},{"issue":"6","key":"10.1016\/j.clinthera.2025.07.022_bib0029","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1515\/revneuro-2022-0096","article-title":"Targeting NMDA receptor signaling for therapeutic intervention in brain disorders","volume":"34","author":"Chen","year":"2023","journal-title":"Rev Neurosci"},{"issue":"2","key":"10.1016\/j.clinthera.2025.07.022_bib0030","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00429-014-0934-2","article-title":"IGF-1 deficiency causes atrophic changes associated with upregulation of VGluT1 and downregulation of MEF2 transcription factors in the mouse cochlear nuclei","volume":"221","author":"Fuentes-Santamar\u00eda","year":"2016","journal-title":"Brain Struct Funct"},{"issue":"10","key":"10.1016\/j.clinthera.2025.07.022_bib0031","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.tips.2023.06.008","article-title":"Trofinetide: a pioneering treatment for rett syndrome","volume":"44","author":"Parent","year":"2023","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.clinthera.2025.07.022_bib0032","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12017-013-8236-z","article-title":"Mechanism of action for NNZ-2566 anti-inflammatory effects following PBBI involves upregulation of immunomodulator ATF3","volume":"15","author":"Cartagena","year":"2013","journal-title":"NeuroMol Med"},{"issue":"4","key":"10.1016\/j.clinthera.2025.07.022_bib0033","first-page":"661","article-title":"Associations between neuropsychological, neurobehavioral and emotional functioning and either narcolepsy or idiopathic hypersomnia in children and adolescents","volume":"14","author":"Ludwig","year":"2018","journal-title":"J Clin Sleep Med: JCSM: Off Publ Am Acad Sleep Med"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825002656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825002656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:33:53Z","timestamp":1772814833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291825002656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0149291825002656"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.07.022","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety Profiles of Trofinetide in Pediatric Rett Syndrome Population: A Real-World Postmarketing Pharmacovigilance Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}